A Case of Pulmonary Arterial Hypertension: The Challenge of Improving Outcomes CME

Author Information and Disclosures

Release Date: June 30, 2008; Valid for credit through June 30, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Actelion
Learning Objectives
Upon completion of this activity, participants will be able to:
  1. Discuss the current data on life expectancy and long-term management of pulmonary arterial hypertension
  2. Evaluate new treatment options for pulmonary arterial hypertension, including combination therapy
  3. Consider the importance of adherence to treatment and identify possible barriers to adherence in patients with pulmonary arterial hypertension
Authors and Disclosures

Fernando Torres, MD
Disclosure: Fernando Torres, MD, has disclosed that he has received grants for clinical research from United Therapeutics, Gilead, and Actelion. Dr. Torres has also disclosed that he has served as an advisor or consultant to United Therapeutics, Gilead, and Actelion, and has served as a speaker for United Therapeutics, Gilead, Actelion, and Pfizer.


Jennifer Brown, PhD
Disclosure: Jennifer Brown, PhD, has disclosed no relevant financial relationships.


Christopher J. Lettieri, MD
Disclosure: Christopher J. Lettieri, MD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.